In contrast to NSCLC, GABARAP is also able to regulate epithelial-stromal transformation (EMT) in BC via the AKT/mTOR signaling pathway, thereby inhibiting the proliferation and invasion of breast cancer cells (72). Here, AKT1 is linked to breast carcinoma.